Bortezomib for Injection (2018-04-18)
- Starting date:
- April 18, 2018
- Posting date:
- April 19, 2018
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-66582
Affected Products
Bortezomib for Injection
Reason
Potential for presence of particulate matter (glass) in affected lot.
Depth of distribution
Wholesalers, retailers and healthcare establishments (BC, SK, MB, ON, Que, NS, Nfld)
Affected products
Bortezomib for Injection
DIN, NPN, DIN-HIM
DIN 02423405Dosage form
Powder for solution
Strength
Bortezomib, 3.5mg/vial
Lot or serial number
9501016
Companies
- Recalling Firm
- Teva Canada Inc. 30 Novopharm Court Toronto, Ontario M1B 2K9
- Marketing Authorization Holder
- Teva Canada Inc. 30 Novopharm Court Toronto, Ontario M1B 2K9